Cargando…

Cancer-Associated Fibroblasts: The Origin, Biological Characteristics and Role in Cancer—A Glance on Colorectal Cancer

SIMPLE SUMMARY: Tumor microenvironment is a major contributor to tumor growth, metastasis and resistance to therapy. It consists of many cancer-associated fibroblasts (CAFs), which derive from different types of cells. CAFs detected in different tumor types are linked to poor prognosis, as in the ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Fotsitzoudis, Charalampos, Koulouridi, Asimina, Messaritakis, Ippokratis, Konstantinidis, Theocharis, Gouvas, Nikolaos, Tsiaoussis, John, Souglakos, John
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9497276/
https://www.ncbi.nlm.nih.gov/pubmed/36139552
http://dx.doi.org/10.3390/cancers14184394
_version_ 1784794472744222720
author Fotsitzoudis, Charalampos
Koulouridi, Asimina
Messaritakis, Ippokratis
Konstantinidis, Theocharis
Gouvas, Nikolaos
Tsiaoussis, John
Souglakos, John
author_facet Fotsitzoudis, Charalampos
Koulouridi, Asimina
Messaritakis, Ippokratis
Konstantinidis, Theocharis
Gouvas, Nikolaos
Tsiaoussis, John
Souglakos, John
author_sort Fotsitzoudis, Charalampos
collection PubMed
description SIMPLE SUMMARY: Tumor microenvironment is a major contributor to tumor growth, metastasis and resistance to therapy. It consists of many cancer-associated fibroblasts (CAFs), which derive from different types of cells. CAFs detected in different tumor types are linked to poor prognosis, as in the case of colorectal cancer. Although their functions differ according to their subtype, their detection is not easy, and there are no established markers for such detection. They are possible targets for therapeutic treatment. Many trials are ongoing for their use as a prognostic factor and as a treatment target. More research remains to be carried out to establish their role in prognosis and treatment. ABSTRACT: The therapeutic approaches to cancer remain a considerable target for all scientists around the world. Although new cancer treatments are an everyday phenomenon, cancer still remains one of the leading mortality causes. Colorectal cancer (CRC) remains in this category, although patients with CRC may have better survival compared with other malignancies. Not only the tumor but also its environment, what we call the tumor microenvironment (TME), seem to contribute to cancer progression and resistance to therapy. TME consists of different molecules and cells. Cancer-associated fibroblasts are a major component. They arise from normal fibroblasts and other normal cells through various pathways. Their role seems to contribute to cancer promotion, participating in tumorigenesis, proliferation, growth, invasion, metastasis and resistance to treatment. Different markers, such as a-SMA, FAP, PDGFR-β, periostin, have been used for the detection of cancer-associated fibroblasts (CAFs). Their detection is important for two main reasons; research has shown that their existence is correlated with prognosis, and they are already under evaluation as a possible target for treatment. However, extensive research is warranted.
format Online
Article
Text
id pubmed-9497276
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-94972762022-09-23 Cancer-Associated Fibroblasts: The Origin, Biological Characteristics and Role in Cancer—A Glance on Colorectal Cancer Fotsitzoudis, Charalampos Koulouridi, Asimina Messaritakis, Ippokratis Konstantinidis, Theocharis Gouvas, Nikolaos Tsiaoussis, John Souglakos, John Cancers (Basel) Review SIMPLE SUMMARY: Tumor microenvironment is a major contributor to tumor growth, metastasis and resistance to therapy. It consists of many cancer-associated fibroblasts (CAFs), which derive from different types of cells. CAFs detected in different tumor types are linked to poor prognosis, as in the case of colorectal cancer. Although their functions differ according to their subtype, their detection is not easy, and there are no established markers for such detection. They are possible targets for therapeutic treatment. Many trials are ongoing for their use as a prognostic factor and as a treatment target. More research remains to be carried out to establish their role in prognosis and treatment. ABSTRACT: The therapeutic approaches to cancer remain a considerable target for all scientists around the world. Although new cancer treatments are an everyday phenomenon, cancer still remains one of the leading mortality causes. Colorectal cancer (CRC) remains in this category, although patients with CRC may have better survival compared with other malignancies. Not only the tumor but also its environment, what we call the tumor microenvironment (TME), seem to contribute to cancer progression and resistance to therapy. TME consists of different molecules and cells. Cancer-associated fibroblasts are a major component. They arise from normal fibroblasts and other normal cells through various pathways. Their role seems to contribute to cancer promotion, participating in tumorigenesis, proliferation, growth, invasion, metastasis and resistance to treatment. Different markers, such as a-SMA, FAP, PDGFR-β, periostin, have been used for the detection of cancer-associated fibroblasts (CAFs). Their detection is important for two main reasons; research has shown that their existence is correlated with prognosis, and they are already under evaluation as a possible target for treatment. However, extensive research is warranted. MDPI 2022-09-09 /pmc/articles/PMC9497276/ /pubmed/36139552 http://dx.doi.org/10.3390/cancers14184394 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Fotsitzoudis, Charalampos
Koulouridi, Asimina
Messaritakis, Ippokratis
Konstantinidis, Theocharis
Gouvas, Nikolaos
Tsiaoussis, John
Souglakos, John
Cancer-Associated Fibroblasts: The Origin, Biological Characteristics and Role in Cancer—A Glance on Colorectal Cancer
title Cancer-Associated Fibroblasts: The Origin, Biological Characteristics and Role in Cancer—A Glance on Colorectal Cancer
title_full Cancer-Associated Fibroblasts: The Origin, Biological Characteristics and Role in Cancer—A Glance on Colorectal Cancer
title_fullStr Cancer-Associated Fibroblasts: The Origin, Biological Characteristics and Role in Cancer—A Glance on Colorectal Cancer
title_full_unstemmed Cancer-Associated Fibroblasts: The Origin, Biological Characteristics and Role in Cancer—A Glance on Colorectal Cancer
title_short Cancer-Associated Fibroblasts: The Origin, Biological Characteristics and Role in Cancer—A Glance on Colorectal Cancer
title_sort cancer-associated fibroblasts: the origin, biological characteristics and role in cancer—a glance on colorectal cancer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9497276/
https://www.ncbi.nlm.nih.gov/pubmed/36139552
http://dx.doi.org/10.3390/cancers14184394
work_keys_str_mv AT fotsitzoudischaralampos cancerassociatedfibroblaststheoriginbiologicalcharacteristicsandroleincanceraglanceoncolorectalcancer
AT koulouridiasimina cancerassociatedfibroblaststheoriginbiologicalcharacteristicsandroleincanceraglanceoncolorectalcancer
AT messaritakisippokratis cancerassociatedfibroblaststheoriginbiologicalcharacteristicsandroleincanceraglanceoncolorectalcancer
AT konstantinidistheocharis cancerassociatedfibroblaststheoriginbiologicalcharacteristicsandroleincanceraglanceoncolorectalcancer
AT gouvasnikolaos cancerassociatedfibroblaststheoriginbiologicalcharacteristicsandroleincanceraglanceoncolorectalcancer
AT tsiaoussisjohn cancerassociatedfibroblaststheoriginbiologicalcharacteristicsandroleincanceraglanceoncolorectalcancer
AT souglakosjohn cancerassociatedfibroblaststheoriginbiologicalcharacteristicsandroleincanceraglanceoncolorectalcancer